Menu
 
Research menu
Jump to menu

Publications:  Prof David Baker

von Kutzleben S, Pryce G, Giovannoni G et al. (2016) . Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.Immunology
10.1111/imm.12696
Liu B, Song S, Ruz-Maldonado I et al. (2016) . GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.Diabetes Obes Metab vol. 18, (12) 1263-1273.
10.1111/dom.12780
Baker D, Anandhakrishnan A, Tuite-Dalton KA et al. (2016) . How to refer to people with disease in research outputs: The disconnection between academic practise and that preferred by people with multiple sclerosis.Mult Scler Relat Disord vol. 10, 127-133.
10.1016/j.msard.2016.09.007
Agahozo MC, Peferoen L, Baker D et al. (2016) . CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis – Targeting T or B cells?.Multiple Sclerosis and Related Disorders vol. 9, Article C, 110-117.
10.1016/j.msard.2016.07.011
http://qmro.qmul.ac.uk/xmlui/handle/123456789/15382
Sevastou I, Pryce G, Baker D et al. (2016) . Characterisation of Transcriptional Changes in the Spinal Cord of the Progressive Experimental Autoimmune Encephalomyelitis Biozzi ABH Mouse Model by RNA Sequencing.PLOS ONE vol. 11, (6) e0157754-e0157754.
10.1371/journal.pone.0157754
http://qmro.qmul.ac.uk/xmlui/handle/123456789/13513
Baker D (2016) . Moving from bench to bedside to treat MS.IRISH JOURNAL OF MEDICAL SCIENCE vol. 185, S175-S175.
Ummenthum K, Peferoen LAN, Finardi A et al. (2016) . Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.Eur J Immunol vol. 46, (3) 701-711.
10.1002/eji.201545950
http://qmro.qmul.ac.uk/xmlui/handle/123456789/13679
Warne J, Pryce G, Hill JM et al. (2016) . Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis.J Biol Chem vol. 291, (9) 4356-4373.
10.1074/jbc.M115.700385
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11312
Pryce G, Riddall DR, Selwood DL et al. (2015) . Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.Journal of Neuroimmune Pharmacology vol. 10, (2) 281-292.
10.1007/s11481-014-9575-8
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11925
Pakpoor J, Disanto G, Altmann DR et al. (2015) . No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.Neurol Neuroimmunol Neuroinflamm vol. 2, (6)
10.1212/NXI.0000000000000158
http://qmro.qmul.ac.uk/xmlui/handle/123456789/12681
Ruz Maldonado I, Pingitore A, Liu B et al. (2015) . Stimulation of insulin secretion by cannabinoid ligands LH-21 and Abn-CBD in mouse and human islets: evaluation of the role of GPR55. DIABETOLOGIA. vol. 58, S86-S86.
Pryce G, Baker D (2015) . Cannabinoids fail to show evidence of slowing down the progression of multiple sclerosis.Evid Based Med vol. 20, (4)
10.1136/ebmed-2015-110198
Vainchtein I, Vinet J, Al-Izki S et al. (2015) . Microglia are involved in apoptotic clearance during chronic-relapsing EAE. GLIA. vol. 63, E353-E353.
Ramaglia V, Jackson SJ, Hughes TR et al. (2015) . Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.Clinical and Experimental Immunology vol. 180, (3) 432-441.
10.1111/cei.12595
Ramaglia V, Jackson SJ, Hughes TR et al. (2015) . Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.Clin Exp Immunol vol. 180, (3) 432-441.
10.1111/cei.12595
Wu D, Cerutti C, Lopez-Ramirez MA et al. (2015) . Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation.J Cereb Blood Flow Metab vol. 35, (3) 412-423.
10.1038/jcbfm.2014.207
http://qmro.qmul.ac.uk/xmlui/handle/123456789/9649
Wu D, Cerutti C, Lopez-Ramirez MA et al. (2015) . Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation.Journal of Perinatology vol. 35, (3) 412-423.
10.1038/jcbfm.2014.207
Biela A, Watkinson M, Meier UC et al. (2015) . Disposable MMP-9 sensor based on the degradation of peptide cross-linked hydrogel films using electrochemical impedance spectroscopy.Biosensors and Bioelectronics vol. 68, 660-667.
10.1016/j.bios.2015.01.060
http://qmro.qmul.ac.uk/xmlui/handle/123456789/9710
Pryce G, Baker D (2015) . Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.Handb Exp Pharmacol vol. 231, 213-231.
10.1007/978-3-319-20825-1_7
Baker D, Amor S (2015) . Mouse models of multiple sclerosis: lost in translation?.Curr Pharm Des vol. 21, (18) 2440-2452.
10.2174/1381612821666150316122706
Giovannoni G, Baker D, Schmierer K (2015) . The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?.Mult Scler Relat Disord vol. 4, (1) 3-5.
10.1016/j.msard.2014.11.005
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11979
Von Kutzleben S, Pryce G, Chretien N et al. (2014) . Inhibition of relapsing experimental autoimmune encephalomyelitis in Biozzi ABH mice using a mouse CD52-specific monoclonal antibody. JOURNAL OF NEUROIMMUNOLOGY. vol. 275, 228-228.
10.1016/j.jneuroim.2014.08.611
Pakpoor J, Disanto G, Altmann DR et al. (2014) . CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 85,
10.1136/jnnp-2014-309236.140
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7246
Giovannoni G, Baker D, Schmierer K (2014) . Simvastatin in patients with progressive multiple sclerosis.Lancet vol. 384, (9947)
10.1016/S0140-6736(14)61621-4
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11982
Pakpoor J, Nyein S, Disanto G et al. (2014) . A global analysis of the use of social media to discuss multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL. vol. 20, 334-335.
Liu B, Song S, Baker D et al. (2014) . Knockout of GPR55 impairs insulin secretion and reduces islet cell turnover.DIABETOLOGIA vol. 57, S49-S49.
Amor S, van der Star BJ, Bosca I et al. (2014) . Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.Mult Scler vol. 20, (10) 1355-1362.
10.1177/1352458514521887
Lopez-Ramirez MA, Wu D, Pryce G et al. (2014) . MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation.FASEB J vol. 28, (6) 2551-2565.
10.1096/fj.13-248880
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7990
Browne L, Lidster K, Al-Izki S et al. (2014) . Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.J Med Chem vol. 57, (7) 2942-2952.
10.1021/jm401881q
Liu B, Song S, Baker D et al. (2014) . GPR55 deletion is coupled to impaired insulin secretion and reduced islet cell turnover.DIABETIC MEDICINE vol. 31, 9-9.
Puentes F, Topping J, Kuhle J et al. (2014) . Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.Journal of Neurology, Neurosurgery and Psychiatry vol. 85, (3) 274-278.
10.1136/jnnp-2013-305494
Puentes F, Topping J, Kuhle J et al. (2014) . Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.J Neurol Neurosurg Psychiatry vol. 85, (3) 274-278.
10.1136/jnnp-2013-305494
Song S, Liu B, Bowe JE et al. (2014) . Specificity of GPR55 agonists and antagonist in the regulation of calcium handling and insulin secretion by mouse islets.DIABETIC MEDICINE vol. 31, 32-32.
Van Den Elsen PJ, Van Eggermond MCJA, Puentes F et al. (2014) . The epigenetics of multiple sclerosis and other related disorders.Multiple Sclerosis and Related Disorders vol. 3, (2) 163-175.
10.1016/j.msard.2013.08.007
Whyte L, Khalid A, Finnie G et al. (2014) . GPR55 Regulates Peak Bone Mass and Steroid Hormone Levels in Male Mice. JOURNAL OF BONE AND MINERAL RESEARCH. vol. 29, S409-S409.
Pryce G, Visintin C, Ramagopalan SV et al. (2014) . Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists.FASEB J vol. 28, (1) 117-130.
10.1096/fj.13-239442
Baker D, Amor S (2014) . Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely.Multiple Sclerosis and Related Disorders
10.1016/j.msard.2014.05.002
Puentes F, Topping J, Kuhle J et al. (2014) . Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.Journal of Neurology, Neurosurgery and Psychiatry vol. 85, (3) 274-278.
Amor S, Peferoen LAN, Vogel DYS et al. (2014) . Inflammation in neurodegenerative diseases - an update.Immunology vol. 142, (2) 151-166.
10.1111/imm.12233
Mullen L, Rigby A, Sclanders M et al. (2014) . Latency can be conferred to a variety of cytokines by fusion with latency-associated peptide from TGF-β.Expert Opin Drug Deliv vol. 11, (1) 5-16.
10.1517/17425247.2013.839655
Mullen L, Adams G, Layward L et al. (2014) . Latent cytokines for targeted therapy of inflammatory disorders.Expert Opin Drug Deliv vol. 11, (1) 101-110.
10.1517/17425247.2014.863872
Al-Izki S, Pryce G, Hankey DJR et al. (2014) . Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.Brain vol. 137, (1) 92-108.
10.1093/brain/awt324
Al-Izki S, Pryce G, Hankey DJ et al. (2014) . Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.Brain vol. 137, (Pt 1) 92-108.
10.1093/brain/awt324
http://qmro.qmul.ac.uk/xmlui/handle/123456789/9650
Baker D, Pepper G, Yauner F et al. (2014) . MSer - A new, neutral descriptor for someone with multiple sclerosis.Multiple Sclerosis and Related Disorders vol. 3, (1) 31-33.
10.1016/j.msard.2013.06.010
Baker D, Lidster K, Sottomayor A et al. (2014) . Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies.PLoS Biol vol. 12, (1)
10.1371/journal.pbio.1001756
http://qmro.qmul.ac.uk/xmlui/handle/123456789/10590
Hampton DW, Serio A, Pryce G et al. (2013) . Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis.Acta Neuropathol Commun vol. 1,
10.1186/2051-5960-1-84
Pryce G, Cabranes A, Fernández-Ruiz J et al. (2013) . Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.Mult Scler vol. 19, (14) 1896-1904.
10.1177/1352458513485982
Delarasse C, Smith P, Baker D et al. (2013) . Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice.Immunology vol. 140, (4) 456-464.
10.1111/imm.12155
James E, Dobson R, Kuhle J et al. (2013) . The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis.Mult Scler vol. 19, (12) 1571-1579.
10.1177/1352458513489756
Puentes F, van der Star BJ, Victor M et al. (2013) . Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.Journal of Neuroinflammation vol. 10,
10.1186/1742-2094-10-118
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7824
Liu B, Song S, Baker D et al. (2013) . GPR55 deletion is coupled to impaired glucose tolerance and increased islet cell apoptosis. DIABETOLOGIA. vol. 56, S46-S46.
Di Filippo M, Chiasserini D, Gardoni F et al. (2013) . Effects of central and peripheral inflammation on hippocampal synaptic plasticity.NEUROBIOLOGY OF DISEASE vol. 52, 229-236.
10.1016/j.nbd.2012.12.009
Baker D, Lidster K, Al-Izki S et al. (2013) . Animal models of progressive disability in MS.IRISH JOURNAL OF MEDICAL SCIENCE vol. 182, S5-S6.
Sisay S, Pryce G, Jackson SJ et al. (2013) . Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis.PLoS One vol. 8, (10)
10.1371/journal.pone.0076907
http://qmro.qmul.ac.uk/xmlui/handle/123456789/6281
Baker D, Pepper G, Yauner F et al. (2013) . MSer - A new, neutral descriptor for someone with multiple sclerosis.Multiple Sclerosis and Related Disorders
10.1016/j.msard.2013.06.010
Lidster K, Jackson SJ, Ahmed Z et al. (2013) . Neuroprotection in a novel mouse model of multiple sclerosis.PLoS One vol. 8, (11)
10.1371/journal.pone.0079188
http://qmro.qmul.ac.uk/xmlui/handle/123456789/10591
van den Elsen PJ, van Eggermond MCJA, Puentes F et al. (2013) . The epigenetics of multiple sclerosis and other related disorders.Multiple Sclerosis and Related Disorders
10.1016/j.msard.2013.08.007
Lopez-Ramirez MA, Wu D, Pryce G et al. (2012) . Endothelial miR-155 promotes blood brain barrier dysfunction in neuroinflammation. JOURNAL OF NEUROIMMUNOLOGY. vol. 253, 3-4.
van der Star B, Puentes F, Gerritsen W et al. (2012) . Neuronal specific T cells are pathogenic in Biozzi mice - Implications for MS. JOURNAL OF NEUROIMMUNOLOGY. vol. 253, 155-155.
Baker D, Lidster K, Sottomayor A et al. (2012) . Reproducibility: Research-reporting standards fall short.Nature vol. 492, (7427)
10.1038/492041a
Fox RJ, Thompson A, Baker D et al. (2012) . Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.MULTIPLE SCLEROSIS JOURNAL vol. 18, (11) 1534-1540.
10.1177/1352458512458169
http://qmro.qmul.ac.uk/xmlui/handle/123456789/10916
Song S, Liu B, Baker D et al. (2012) . Islet GPR55 is coupled to increased insulin secretion and decreased apoptosis.DIABETOLOGIA vol. 55, S163-S163.
Li C, Bowe JE, Baker D et al. (2012) . PS 014 Beta cell GPCRs and other signalling mechanisms.DIABETOLOGIA vol. 55, S163-S163.
van der Star BJ, Vogel DYS, Kipp M et al. (2012) . In Vitro and In Vivo Models of Multiple Sclerosis.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS vol. 11, (5) 570-588.
10.2174/187152712801661284
van Noort JM, Baker D, Amor S (2012) . Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS vol. 11, (5) 556-569.
10.2174/187152712801661293
Baker D, Amor S (2012) . Multiple sclerosis - from bench to bedside.CNS Neurol Disord Drug Targets vol. 11, (5) 495-496.
10.2174/187152712801661211
Lidster K, Baker D (2012) . Optical coherence tomography detection of neurodegeneration in multiple sclerosis.CNS Neurol Disord Drug Targets vol. 11, (5) 518-527.
10.2174/187152712801661185
Pryce G, Baker D (2012) . Potential control of multiple sclerosis by cannabis and the endocannabinoid system.CNS Neurol Disord Drug Targets vol. 11, (5) 624-641.
10.2174/187152712801661310
Amor S, Baker D (2012) . Checklist for reporting and reviewing studies of experimental animal models of multiple sclerosis and related disorders.Multiple Sclerosis and Related Disorders vol. 1, (3) 111-115.
10.1016/j.msard.2012.01.003
Gnanapavan S, Grant D, Pryce G et al. (2012) . Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis.Autoimmunity vol. 45, (4) 298-303.
10.3109/08916934.2012.654865
Baker D, Pryce G, Jackson SJ et al. (2012) . The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis.Multiple Sclerosis and Related Disorders vol. 1, (2) 64-75.
10.1016/j.msard.2011.11.001
Baker D, Amor S (2012) . Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis.J Neuroimmunol vol. 242, (1-2) 78-83.
10.1016/j.jneuroim.2011.11.003
Kipp M, Van Der Star B, Vogel DYS et al. (2012) . Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond.Multiple Sclerosis and Related Disorders vol. 1, (1) 15-28.
10.1016/j.msard.2011.09.002
Sher F, Amor S, Gerritsen W et al. (2012) . Intraventricularly Injected Olig2-NSCs Attenuate Established Relapsing-Remitting EAE in Mice.CELL TRANSPLANTATION vol. 21, (9) 1883-1897.
10.3727/096368911X637443
Al-Izki S, Pryce G, O apos Neill JK et al. (2012) . Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.Multiple Sclerosis and Related Disorders vol. 1, (1) 29-38.
10.1016/j.msard.2011.09.001
Puentes F, van der Star B, Huizinga R et al. (2011) . Autoimmunity to axonal proteins in multiple sclerosis.MULTIPLE SCLEROSIS JOURNAL vol. 17, S329-S329.
Jackson S, Giovannoni G, Baker D (2011) . Fingolimod (FTY720) modulates microglial activation to augment markers of remyelination.MULTIPLE SCLEROSIS JOURNAL vol. 17, S210-S210.
Lidster K, Jackson S, Coffey P et al. (2011) . Neuroprotection in a novel optic neuritis model.MULTIPLE SCLEROSIS JOURNAL vol. 17, S435-S435.
Al-Izki S, Pryce G, Amor S et al. (2011) . Selective targeting of neuroprotection to MS lesions: sodium channel blockers in experimental autoimmune encephalomyelitis.MULTIPLE SCLEROSIS JOURNAL vol. 17, S209-S210.
Pryce G, Visintin C, Lutz B et al. (2011) . Selective targeting of spasticity by CNS-excluded cannabinoids.MULTIPLE SCLEROSIS JOURNAL vol. 17, S247-S247.
Baker D, Pryce G, Visintin C et al. (2011) . VSN16R a novel agent for the control of spasticity.MULTIPLE SCLEROSIS JOURNAL vol. 17, S243-S243.
Ayoub SS, Pryce G, Seed MP et al. (2011) . Paracetamol-induced hypothermia is independent of cannabinoids and transient receptor potential vanilloid-1 and is not mediated by AM404.Drug Metab Dispos vol. 39, (9) 1689-1695.
10.1124/dmd.111.038638
Al-Izki S, Pryce G, Jackson SJ et al. (2011) . Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis.Mult Scler vol. 17, (8) 939-948.
10.1177/1352458511400476
Jackson SJ, Giovannoni G, Baker D (2011) . Fingolimod modulates microglial activation to augment markers of remyelination.J Neuroinflammation vol. 8,
10.1186/1742-2094-8-76
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7825
Baker D, Gerritsen W, Rundle J et al. (2011) . Critical appraisal of animal models of multiple sclerosis.Mult Scler vol. 17, (6) 647-657.
10.1177/1352458511398885
Baker D, Amor S (2010) . Editorial: Quality control of experimental autoimmune encephalomyelitis.Multiple Sclerosis vol. 16, (9) 1025-1027.
10.1177/1352458510378317
Baker D, Amor S (2010) . Quality control of experimental autoimmune encephalomyelitis.Mult Scler vol. 16, (9) 1025-1027.
10.1177/1352458510378317
Amor S, Puentes F, Baker D et al. (2010) . Inflammation in neurodegenerative diseases.IMMUNOLOGY vol. 129, (2) 154-169.
10.1111/j.1365-2567.2009.03225.x
Idris AI, Sophocleous A, Landao-Bassonga E et al. (2009) . Cannabinoid Receptor Type 1 Protects against Age-Related Osteoporosis by Regulating Osteoblast and Adipocyte Differentiation in Marrow Stromal Cells.CELL METAB vol. 10, (2) 139-147.
10.1016/j.cmet.2009.07.006
Al-Izki S, Pryce G, Giovannoni G et al. (2009) . Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high-resolution ultrasonography.Mult Scler vol. 15, (7) 795-801.
10.1177/1352458509104594
Idris AI, Sophocleous A, Landao-Bassonga E et al. (2009) . Cannabinoid receptor type 1 protects against age-related bone loss by regulating osteoblast and adipocyte differentiation of bone marrow stromal cells. BONE. vol. 44, S222-S222.
10.1016/j.bone.2009.03.067
Hooper C, Pinteaux-Jones F, Fry V et al. (2009) . Differential effects of albumin on microglia and macrophages; implications for neurodegeneration following blood-brain barrier damage.J Neurochem vol. 109, (3) 694-705.
10.1111/j.1471-4159.2009.05953.x
Amor S, Baker D (2009) . Experimental autoimmune encephalomyelitis.The Biology of Multiple Sclerosis,
Rigby A, Baker D, Chernajovsky Y (2008) . Targeting EPO to the CNS; development of a novel therapeutic strategy. IMMUNOLOGY. vol. 125, 134-135.
Hampton DW, Anderson J, Pryce G et al. (2008) . An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss.J NEUROIMMUNOL vol. 201, 200-211.
10.1016/j.jneuroim.2008.05.034
Jackson S, Al-Izik S, Pryce G et al. (2008) . Fingolimod reduces axonal loss in relapsing secondary progressive experimental autoimmune encephalomyelitis. MULTIPLE SCLEROSIS. vol. 14, S80-S81.
Parkes H, Shorter S, So PW et al. (2008) . High resolution 1H nuclear magnetic resonance spectroscopic-based metabolomic urine analysis of experimental autoimmune encephalitis, a model disease of multiple sclerosis. MULTIPLE SCLEROSIS. vol. 14, S86-S87.
Al-Izki S, Pryce G, Jackson S et al. (2008) . Neuroprotective effects of omega-3 fatty acids in a mouse model of multiple sclerosis. JOURNAL OF NEUROIMMUNOLOGY. vol. 197, 173-173.
Rigby A, Chernajovsky Y, Baker D (2008) . Targeting EPO to the CNS; Development of a novel therapeutic strategy. JOURNAL OF NEUROIMMUNOLOGY. vol. 197, 171-171.
Anderson JM, Hampton DW, Patani R et al. (2008) . Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis.BRAIN vol. 131, 1736-1748.
10.1093/brain/awn119
Pinteaux-Jones F, Sevastou IG, Fry VAH et al. (2008) . Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors.J NEUROCHEM vol. 106, (1) 442-454.
10.1111/j.1471-4159.2008.05426.x
East E, Gveri¿ D, Baker D et al. (2008) . Chronic relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor-1 knockout mice: the effect of fibrinolysis during neuroinflammation.Neuropathol Appl Neurobiol vol. 34, (2) 216-230.
10.1111/j.1365-2990.2007.00889.x
Croxford JL, Pryce G, Jackson SJ et al. (2008) . Cannabinoid-mediated neuroprotection, not immuno suppression, may be more relevant to multiple sclerosis.J NEUROIMMUNOL vol. 193, (1-2) 120-129.
10.1016/j.jneuroim.2007.10.024
Pryce G, Jackson SJ, Baker D (2008) . Cannabinoids for the control of multiple sclerosis.Cannabinoids and the Brain,
Baker D, Pryce G (2008) . The endocannabinoid system and multiple sclerosis.Curr Pharm Des vol. 14, (23) 2326-2336.
10.2174/138161208785740036
Baker D, Jackson SJ, Pryce G (2007) . Cannabinoid control of neuroinflammation related to multiple sclerosis.BRIT J PHARMACOL vol. 152, (5) 649-654.
10.1038/sj.bjp.0707458
Hoi PM, Visintin C, Okuyama M et al. (2007) . Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl) benzamide (VSN16) in the rat.BRIT J PHARMACOL vol. 152, (5) 751-764.
10.1038/sj.bjp.0707470
Pocock JM, Pinteaux-Jones F, Fry VA et al. (2007) . Metabotropic glutamate receptors on microglia: Switching off toxicity. JOURNAL OF NEUROCHEMISTRY. vol. 102, 239-239.
Maresz K, Pryce G, Ponomarev ED et al. (2007) . Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells.NAT MED vol. 13, (4) 492-497.
10.1038/nm1561
Pryce G, Baker D (2007) . Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.BRIT J PHARMACOL vol. 150, (4) 519-525.
10.1038/sj.bjp.0707003
Baker D, Croxford JL, Pryce G et al. (2006) . Cannabinoid-mediated immunosuppression in experimental allergic encephalomyelitis. JOURNAL OF NEUROIMMUNOLOGY. vol. 178, 90-91.
Baker D (2006) . Protection of axonal damage in experimental antoimmune encephalomyelitis. MULTIPLE SCLEROSIS. vol. 12, S12-S13.
Baker D (2006) . Role of immunity in neurodegeneration in autoimmune encephalomyelitis. JOURNAL OF NEUROIMMUNOLOGY. vol. 178, 20-20.
Cabranes A, Pryce G, Baker D et al. (2006) . Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice.BRAIN RES vol. 1107, 199-205.
10.1016/j.brainres.2006.06.001
Bilsland LG, Dick JRT, Pryce G et al. (2006) . Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice.FASEB J vol. 20, (7) 1003-+.
10.1096/fj.05-4743fje
Baker D, Pryce G, Croxford JL et al. (2006) . Cannabinoid-mediated immunosuppression in experimental allergic encephalomyelitits. CURRENT TOPICS IN NEUROIMMUNOLOGY. Editors: Tabira, T, Yamamura, T, Kira, J, 109-116.
Cristino L, De Petrocellis L, Pryce G et al. (2006) . Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain.NEUROSCIENCE vol. 139, (4) 1405-1415.
10.1016/j.neuroscience.2006.02.074
Baker D, Pryce G, Davies WL et al. (2006) . In silico patent searching reveals a new cannabinoid receptor.TRENDS PHARMACOL SCI vol. 27, (1) 1-4.
10.1016/j.tips.2005.11.003
Ligresti A, Cascio MG, Pryce G et al. (2006) . New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis.BRIT J PHARMACOL vol. 147, (1) 83-91.
10.1038/sj.bjp.0706418
de Lago E, Fernandez-Ruiz J, Ortega-Gutierrez S et al. (2006) . UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.EUR NEUROPSYCHOPHARM vol. 16, (1) 7-18.
10.1016/j.euroneuro.2005.06.001
Heijmans N, Smith PA, Morris-Downes MM et al. (2005) . Encephalitogenic and tolerogenic potential of altered peptide ligands of MOG and PLP in Biozzi ABH mice.J NEUROIMMUNOL vol. 167, (1-2) 23-33.
10.1016/j.jneuroim.2005.06.005
East E, Baker D, Pryce G et al. (2005) . A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis.Am J Pathol vol. 167, (2) 545-554.
10.1016/S0002-9440(10)62996-3
Pryce G, O'Neill JK, Croxford JL et al. (2005) . Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis.J NEUROIMMUNOL vol. 165, (1-2) 41-52.
10.1016/j.jneuroim.2005.04.009
Amor S, Smith PA, 't Hart B et al. (2005) . Biozzi mice: Of mice and human neurological diseases.J NEUROIMMUNOL vol. 165, (1-2) 1-10.
10.1016/j.jneuroim.2005.04.010
Smith PA, Morris-Downes M, Heijmans N et al. (2005) . Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice.J NEUROIMMUNOL vol. 164, (1-2) 76-84.
10.1016/j.jneuroim.2005.04.006
Idris AI, Hof RJV, Greig IR et al. (2005) . Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.NAT MED vol. 11, (7) 774-779.
10.1038/nm1255
Jackson SJ, Diemel LT, Pryce G et al. (2005) . Cannabinoids and neuroprotection in CNS inflammatory disease. JOURNAL OF THE NEUROLOGICAL SCIENCES. vol. 233, 21-25.
10.1016/j.jns.2005.03.002
Idris AI, Van't Hof RJ, Greig IR et al. (2005) . Cannabinoid receptor 1 knockout mice have increased bone mass and are protected from ovariectomy-induced bone loss. BONE. vol. 36, S132-S132.
Pryce G, Baker D (2005) . Emerging properties of cannabinoid medicines in management of multiple sclerosis.TRENDS NEUROSCI vol. 28, (5) 272-276.
10.1016/j.tins.2005.03.006
Visintin C, Aliev AE, Riddall D et al. (2005) . Membrane receptor probes: Solid-phase synthesis of biotin-Asp-PEG-arvanil derivatives.ORG LETT vol. 7, (9) 1699-1702.
10.1021/ol0502578
Gegg ME, Harry R, Hankey D et al. (2005) . Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction.J IMMUNOL vol. 174, (4) 2327-2335.
10.4049/jimmunol.174.4.2327
Jackson SJ, Pryce G, Diemel LT et al. (2005) . Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation.NEUROSCIENCE vol. 134, (1) 261-268.
10.1016/j.neuroscience.2005.02.045
Constantinescu CS, Baker D (2005) . Cytokines in experimental autoimmune encephalomyelitis.Experimental Models of Multiple Sclerosis,
Baker D (2005) . Genetics of experimental allergic encephalomyelitis.Experimental Models of Multiple Sclerosis,
Jackson SJ, Baker D, Cuzner ML et al. (2004) . Cannabinoid-mediated neuroprotection following interferon-gamma treatment in a three-dimensional mouse brain aggregate cell culture.EUR J NEUROSCI vol. 20, (9) 2267-2275.
10.1111/j.1460-9568.2004.03711.x
Idris AI, Van't Hof' RJ, Greig IR et al. (2004) . Regulation of osteoclastic bone resorption and bone mass by the cannabinoid receptor 1 pathway. JOURNAL OF BONE AND MINERAL RESEARCH. vol. 19, S284-S284.
Pryce G, Jackson SM, Hankey DRJ et al. (2004) . Cannabinoids are neuroprotective: dissociation of true neuroprotection from protection secondary to immunosuppression. JOURNAL OF NEUROIMMUNOLOGY. vol. 154, 78-78.
Heijmans N, Smith P, Pryce D et al. (2004) . Non-encephalitogenic single amino acid substitutions of MOG 8-21 and PLP 56-70 suppress relapsing EAE in ABH mice. JOURNAL OF NEUROIMMUNOLOGY. vol. 154, 60-60.
Baker D, Pryce G (2004) . The potential role of the endocannabinoid system in the control of multiple scleorsis.Current Medicinal Chemistry - Central Nervous System Agents vol. 4, (3) 195-202.
10.2174/1568015043356977
East E, Baker D, Pryce G et al. (2004) . The role of plasminogen activators in experimental allergic encephalomyelitis: inflammation and axonal pathology. JOURNAL OF NEUROIMMUNOLOGY. vol. 154, 167-167.
Ellmerich S, Takacs K, Mycko M et al. (2004) . Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis.EUR J IMMUNOL vol. 34, (7) 1839-1848.
10.1002/eji.200324044
de Lago E, Ligresti A, Ortar G et al. (2004) . In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake.EUR J PHARMACOL vol. 484, (2-3) 249-257.
10.1016/j.ejphar.2003.11.027
Wilkinson JD, Whalley BJ, Baker D et al. (2003) . Medicinal cannabis: is Delta(9)-tetrahydrocannabinol necessary for all its effects?.J PHARM PHARMACOL vol. 55, (12) 1687-1694.
10.1211/0022357022304
Pryce G, Ahmed Z, Hankey DJR et al. (2003) . Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.BRAIN vol. 126, 2191-2202.
10.1093/brain/awg224
Craner MJ, Kataoka Y, Lo AC et al. (2003) . Temporal course of upregulation of Na-v 1.8 in Purkinje neurons parallels the progression of clinical deficit in experimental allergic encephalomyelitis.J NEUROPATH EXP NEUR vol. 62, (9) 968-975.
10.1093/jnen/62.9.968
East E, Baker D, Pryce GM et al. (2003) . The role of plasminogen activators in experimental allergic encephalomyelitis. GLIA. 40-40.
Ahmed Z, Baker D, Cuzner ML (2003) . Interleukin-12 induces mild experimental allergic encephalomyelitis following local central nervous system injury in the Lewis rat.J NEUROIMMUNOL vol. 140, (1-2) 109-117.
10.1016/S0165-5728(03)00180-2
Giovannoni G, Baker D (2003) . Inflammatory disorders of the central nervous system.CURR OPIN NEUROL vol. 16, (3) 347-350.
10.1097/01.wco.0000073936.19076.9c
Hall RJ, Hollis-Moffatt JE, Merriman ME et al. (2003) . An autoimmune diabetes locus (Idd21) on mouse Chromosome 18.MAMM GENOME vol. 14, (5) 335-339.
10.1007/s00335-002-3064-8
Baker D, Hankey DJR (2003) . Gene therapy in autoimmune, demyelinating disease of the central nervous system.GENE THER vol. 10, (10) 844-853.
10.1038/sj.gt.3302025
Greenwood J, Walters CE, Pryce G et al. (2003) . Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis.FASEB J vol. 17, (8) 905-907.
10.1096/fj.02-1014fje
Pryce G, Giovannoni G, Baker D (2003) . Mifepristone or inhibition of 11 beta-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Delta(9)-tetrahydrocannabinol in mice.NEUROSCI LETT vol. 341, (2) 164-166.
10.1016/S0304-3940(03)00159-9
Petzold A, Baker D, Pryce G et al. (2003) . Quantification of neurodegeneration by measurement of brain-specific proteins.J NEUROIMMUNOL vol. 138, (1-2) 45-48.
10.1016/S0165-5728(03)00092-4
Baker D, Pryce G, Giovannoni G et al. (2003) . The therapeutic potential of cannabis.LANCET NEUROL vol. 2, (5) 291-298.
10.1016/S1474-4422(03)00381-8
Baker D, Pryce G (2003) . The therapeutic potential of cannabis in multiple sclerosis.EXPERT OPIN INV DRUG vol. 12, (4) 561-567.
10.1517/13543784.12.4.561
Craner MJ, Lo AC, Black JA et al. (2003) . Annexin II/piII is up-regulated in Purkinje cells in EAE and MS.NEUROREPORT vol. 14, (4) 555-558.
10.1097/01.wnr.0000061018.47393.38
Baker D, Adamson P, Greenwood J (2003) . Potential of statins for the treatment of multiple sclerosis.LANCET NEUROL vol. 2, (1) 9-10.
10.1016/S1474-4422(03)00256-4
Ahmed Z, Doward AI, Pryce G et al. (2002) . A role for caspase-1 and-3 in the pathology of experimental allergic encephalomyelitis - Inflammation versus degeneration.AM J PATHOL vol. 161, (5) 1577-1586.
10.1016/S0002-9440(10)64436-7
Hall RJ, Hollis-Moffat JE, Merriman ME et al. (2002) . An autoimmune diabetes locus (ldd21) on mouse chromosome 18. AMERICAN JOURNAL OF HUMAN GENETICS. vol. 71, 446-446.
Thompson AJ, Baker D (2002) . Cannabinoids in MS - Potentially useful but not just yet!.NEUROLOGY vol. 58, (9) 1323-1324.
10.1212/WNL.58.9.1323
Walters CE, Pryce G, Hankey DJR et al. (2002) . Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis.J IMMUNOL vol. 168, (8) 4087-4094.
10.4049/jimmunol.168.8.4087
Morris-Downes MM, Smith PA, Rundle JL et al. (2002) . Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice.J NEUROIMMUNOL vol. 125, (1-2) 114-124.
10.1016/S0165-5728(02)00040-1
Youssef F, Seifalian AM, Jagroop IA et al. (2002) . The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT)dagger.EUR J VASC ENDOVASC vol. 23, (4) 358-364.
10.1053/ejvs.2002.1611
Brooks JW, Pryce G, Bisogno T et al. (2002) . Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors.EUR J PHARMACOL vol. 439, (1-3) 83-92.
10.1016/S0014-2999(02)01369-9
Morris-Downes MM, McCormack K, Baker D et al. (2002) . Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2 ',3 '-cyclic nucleotide 3 '-phosphodiesterase (CNPase) in ABH and SJL mice.J NEUROIMMUNOL vol. 122, (1-2) 20-33.
10.1016/S0165-5728(01)00460-X
Hankey DJR, Nickerson JM, Donoso LA et al. (2001) . Experimental autoimmune uveoretinitis in mice (Biozzi ABH and NOD) expressing the autoimmune-associated H-2A(g7) molecule: identification of a uveitogenic epitope.J NEUROIMMUNOL vol. 118, (2) 212-222.
10.1016/S0165-5728(01)00341-1
Ahmed Z, Gveric D, Pryce G et al. (2001) . Myelin/axonal pathology in interleukin-12 induced serial relapses of experimental allergic encephalomyelitis in the Lewis rat.Am J Pathol vol. 158, (6) 2127-2138.
10.1016/S0002-9440(10)64684-6
Croxford JL, Feldmann M, Chernajovsky Y et al. (2001) . Different therapeutic outcomes in experimental allergic encephalomyelitis dependant upon the mode of delivery of IL-10: A comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system.J IMMUNOL vol. 166, (6) 4124-4130.
10.4049/jimmunol.166.6.4124
Reichel MB, Bainbridge J, Baker D et al. (2001) . An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse.BRIT J OPHTHALMOL vol. 85, (3) 341-344.
10.1136/bjo.85.3.341
Hankey DJR, Lightman SL, Baker D (2001) . Interphotoreceptor retinoid binding protein peptide-induced uveitis in B10.RIII mice: Characterization of disease parameters and immunomodulation.EXP EYE RES vol. 72, (3) 341-350.
10.1006/exer.2000.0957
Baker D, Pryce G, Croxford JL et al. (2001) . Endocannabinoids control spasticity in a multiple sclerosis model.FASEB J vol. 15, (2) 300-302.
10.1096/fj.00-0399fje
Black JA, Dib-Hajj S, Baker D et al. (2000) . Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis.Proceedings of the National Academy of Sciences of the United States of America vol. 97, (21) 11598-11602.
10.1073/pnas.97.21.11598
Chernajovsky Y, Dreja H, Daly G et al. (2000) . Immuno- and genetic therapy in autoimmune diseases.Genes Immun vol. 1, (5) 295-307.
10.1038/sj.gene.6363683
Baker D (2000) . Reply: a sanguine approach to cannabis.Trends Pharmacol Sci vol. 21, (6)
10.1016/S0165-6147(00)01486-3
Thoua NM, van Noort JM, Baker D et al. (2000) . Encephalitogenic and immunogenic potential of the stress protein alpha B-crystallin in Biozzi ABH (H-2A(g7)) mice.JOURNAL OF NEUROIMMUNOLOGY vol. 104, (1) 47-57.
10.1016/S0165-5728(99)00246-5
Baker D, Pryce G, Croxford JL et al. (2000) . Cannabinoids control spasticity and tremor in a multiple sclerosis model.Nature vol. 404, (6773) 84-87.
10.1038/35003583
Croxford JL, Triantaphyllopoulos KA, Neve RM et al. (2000) . Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor.J Immunol vol. 164, (5) 2776-2781.
10.4049/jimmunol.164.5.2776
Chernajovsky Y, Gould D, Annenkov A et al. (1999) . Immunotherapy of auto-immune diseases by gene transfer.Biochem Soc Trans vol. 27, (6) 869-873.
10.1042/bst0270869
Brennan FR, O'Neill JK, Allen SJ et al. (1999) . CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease.Immunology vol. 98, (3) 427-435.
10.1046/j.1365-2567.1999.00894.x
Croxford JL, O'Neill JK, Ali RR et al. (1998) . Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis.Eur J Immunol vol. 28, (12) 3904-3916.
10.1002/(SICI)1521-4141(199812)28:12<3904::AID-IMMU3904>3.0.CO;2-5
Ali RR, Reichel MB, Byrnes AP et al. (1998) . Co-injection of adenovirus expressing CTLA4-Ig prolongs adenovirally mediated lacZ reporter gene expression in the mouse retina.GENE THERAPY vol. 5, (11) 1561-1565.
10.1038/sj.gt.3300761
Reichel MB, Ali RR, Thrasher AJ et al. (1998) . Immune responses limit adenovirally mediated gene expression in the adult mouse eye.Gene Therapy vol. 5, (8) 1038-1046.
10.1038/sj.gt.3300691
Croxford JL, Triantaphyllopoulos K, Podhajcer OL et al. (1998) . Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system.J Immunol vol. 160, (10) 5181-5187.
O'Neill JK, Baker D, Morris MM et al. (1998) . Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: Demyelination and fast axonal transport changes in disease.JOURNAL OF NEUROIMMUNOLOGY vol. 82, (2) 210-218.
10.1016/S0165-5728(97)00203-8
Chernajovsky Y, Annenkov A, Herman C et al. (1998) . Gene therapy for rheumatoid arthritis. Theoretical considerations.Drugs and Aging vol. 12, (1) 29-41.
10.2165/00002512-199812010-00004
Triantaphyllopoulos KA, Croxford JL, Baker D et al. (1998) . Cloning and expression of murine IFNβ and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis.Gene Therapy vol. 5, (2) 253-263.
10.1038/sj.gt.3300570
Reichet MB, All RR, Baker D et al. (1997) . Co-injection of adenovirus expressing CTLA4-IG prolongs adenovirally-mediated lacz reporter gene expression in the mouse retina.Investigative Ophthalmology and Visual Science vol. 38, (4)
Bolton C, O'Neill JK, Allen SJ et al. (1997) . Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids.International Archives of Allergy and Immunology vol. 114, (1) 74-80.
10.1159/000237646
Amor S, Baker D, Layward L et al. (1997) . Multiple sclerosis: Variants on a theme.Immunology Today vol. 18, (8) 368-371.
10.1016/S0167-5699(97)01100-6
Morris MM, Dyson H, Baker D et al. (1997) . Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection.Journal of Neuroimmunology vol. 74, (1-2) 185-197.
10.1016/S0165-5728(96)00786-2
Croxford JL, O'Neill JK, Baker D (1997) . Polygenic control of experimental allergic encephalomyelitis in Biozzi ABH and BALB/c mice.J Neuroimmunol vol. 74, (1-2) 205-211.
10.1016/S0165-5728(96)00219-6
Brennan FR, ONeill JK, Allen SJ et al. (1996) . Anti-CD44 antibody prevents and ameriolates chronic relapsing experimental allergic encephalomyelitis (CREAE) by inhibition leukocyte migration to the CNS.ARTHRITIS AND RHEUMATISM vol. 39, (9) 625-625.
Amor S, O'Neill JK, Morris MM et al. (1996) . Encephalitogenic epitopes of myelin basic protein, proteolipid protein, and myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2A<sup>g7</sup>) mice share an amino acid motif.Journal of Immunology vol. 156, (8) 3000-3008.
Baker D, Rosenwasser OA, O'Neill JK et al. (1995) . Genetic analysis of experimental allergic encephalomyelitis in mice.Journal of Immunology vol. 155, (8) 4046-4051.
Preece NE, Amor S, Baker D et al. (1994) . Experimental encephalomyelitis modulates inositol and taurine in the spinal cord of Biozzi mice.Magn Reson Med vol. 32, (6) 692-697.
10.1002/mrm.1910320603
Baker D, Butler D, Scallon BJ et al. (1994) . Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor‐immunoglobulin fusion proteins.European Journal of Immunology vol. 24, (9) 2040-2048.
10.1002/eji.1830240916
Preece NE, Baker D, Butter C et al. (1993) . Experimental allergic encephalomyelitis raises betaine levels in the spinal cord of strain 13 guinea-pigs.NMR Biomed vol. 6, (3) 194-200.
10.1002/nbm.1940060305
Liu GY, Baker D, Fairchild S et al. (1993) . Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between AB/H and NOD A region molecules.Immunogenetics vol. 37, (4) 296-300.
10.1007/BF00187458
O'Neill JK, Baker D, Davidson AN et al. (1993) . Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies.Journal of Neuroimmunology vol. 45, (1-2) 1-14.
10.1016/0165-5728(93)90157-T
Allen SJ, Baker D, O'Neill JK et al. (1993) . Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse.Cellular Immunology vol. 146, (2) 335-350.
10.1006/cimm.1993.1031
O'Neill JK, Baker D, Turk JL (1992) . Inhibition of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse.J Neuroimmunol vol. 41, (2) 177-187.
10.1016/0165-5728(92)90068-V
O'Neill JK, Baker D, Davison AN et al. (1992) . Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood-brain barrier: elucidation by the action of Brequinar sodium.J Neuroimmunol vol. 38, (1-2) 53-62.
10.1016/0165-5728(92)90090-8
Butter C, O'Neill JK, Baker D et al. (1991) . An immunoelectron microscopical study of the expression of class II major histocompatibility complex during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice.J Neuroimmunol vol. 33, (1) 37-42.
10.1016/0165-5728(91)90032-3
Butter C, Baker D, O'Neill JK et al. (1991) . Mononuclear cell trafficking and plasma protein extravasation into the CNS during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice.J Neurol Sci vol. 104, (1) 9-12.
10.1016/0022-510X(91)90209-P
Baker D, O'Neill JK, Amor S et al. (1991) . Inhibition of chronic relapsing experimental allergic encephalomyelitis in the mouse by the alkyl-lysophospholipid ET-18-OCH<inf>3</inf>.International Journal of Immunopharmacology vol. 13, (4) 385-392.
10.1016/0192-0561(91)90008-U
Watson CM, Davison AN, Baker D et al. (1991) . Suppression of demyelination by mitoxantrone.Int J Immunopharmacol vol. 13, (7) 923-930.
10.1016/0192-0561(91)90045-9
Wilcox CE, Ward AM, Evans A et al. (1990) . Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis.J Neuroimmunol vol. 30, (1) 43-51.
10.1016/0165-5728(90)90051-N
Butter C, Healey DG, Baker D et al. (1989) . A quantitative immunocytochemical study of the infiltrating lymphocytes in the spinal cord of guinea pigs with chronic relapsing experimental allergic encephalomyelitis.J Neuroimmunol vol. 25, (2-3) 169-176.
10.1016/0165-5728(89)90134-3
Wilcox CE, Healey DG, Baker D et al. (1989) . Presentation of myelin basic protein by normal guinea-pig brain endothelial cells and its relevance to experimental allergic encephalomyelitis.Immunology vol. 67, (4) 435-440.
Wilcox CE, Baker D, Butter C et al. (1989) . Differential expression of guinea pig class II major histocompatibility complex antigens on vascular endothelial cells in vitro and in experimental allergic encephalomyelitis.Cell Immunol vol. 120, (1) 82-91.
10.1016/0008-8749(89)90176-7
BAKER D, PARKER DD, TURK JL (1985) . Effect of depletion of epidermal dendritic cells on the induction of contact sensitivity in the guinea‐pig.British Journal of Dermatology vol. 113, (3) 285-294.
10.1111/j.1365-2133.1985.tb02080.x
Peferoen LAN, Breur M, van de Berg S et al.. Ageing and recurrent episodes of neuroinflammation promote progressive eae in biozzi abh mice.Immunology
10.1111/imm.12644
http://qmro.qmul.ac.uk/xmlui/handle/123456789/13480
BAKER D, POSADA CG, SELWOOD D et al.. Indazole derivatives and their use for blockading voltage gated sodium channels. no. EP20100760746 201009,
BAKER D, Turk JL, Feldmann M. Method for treating multiple sclerosis.
BAKER D. SPATIAL DISTRIBUTION OF THE CANNABINOID TYPE 1 AND CAPSAICIN RECEPTORS MAY CONTRIBUTE TO THE COMPLEXITY OF THEIR CROSSTALK.Scientific Reports
10.1038/srep33307
http://qmro.qmul.ac.uk/xmlui/handle/123456789/15973
Return to top